Sagent Pharmaceuticals recalls Oxacillin for Injection, USP, 2 grams per vial, For IV or IM Use, Rx only, labeled as a) NDC 25021-162-24 and b) novaplu
Recalled August 2, 2023 · FDA recall D-0936-2023 · Sagent Pharmaceuticals
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
65,710 vials for 1 g and 2 g strength
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility
Product
Oxacillin for Injection, USP, 2 grams per vial, For IV or IM Use, Rx only, labeled as a) NDC 25021-162-24 and b) novaplus NDC 25021-162-68, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India.
Manufacturer(s)
Sagent Pharmaceuticals
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →